STOCK TITAN

Valion Bio, Inc. (VBIO) Net Income by Year

VBIO

Valion Bio, Inc. reported a net loss of $8.9M in fiscal year 2025. This represents a decrease of 57.0% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Valion Bio, Inc. has filed alongside them.

FY2025 annual
Net Income -$8.9M
YoY -57.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VBIO Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-K
Net Income-$8.9M-57.0%-$5.7M+31.4%-$8.2M+18.3%-$10.1M-18.9%-$8.5M

VBIO Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$7.1M-267.8%-$6.2M-312.9%N/A-$2.6M-81.4%-$1.9M-52.5%-$1.5M-1.4%-$1.5M+34.2%-$1.4M+18.7%-$1.3M+40.4%-$1.5M+30.0%-$2.2M+0.5%-$1.8M+31.9%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Valion Bio, Inc. financials

Frequently Asked Questions

What was Valion Bio, Inc.'s net income in fiscal year 2025?

Valion Bio, Inc. reported a net loss of $8.9M in fiscal year 2025.

How fast is Valion Bio, Inc.'s net income growing?

Valion Bio, Inc. (VBIO) net income fell by 57.0% year over year, from -$5.7M to -$8.9M in fiscal year 2025.

How has Valion Bio, Inc.'s net income changed over the years?

Across the 5 fiscal years this page covers, Valion Bio, Inc. (VBIO) net income went from -$8.5M in fiscal year 2021 to -$8.9M in fiscal year 2025.

Valion Bio, Inc. (VBIO) reported -$7.1M in net income in Q2 2026. This represents a decrease of 267.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Valion Bio, Inc. (VBIO) reported on that line in every period on record.